Y-Intercept (HK)’s Humacyte HUMA Stock Holding History

Y-Intercept (HK)’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.4K	Buy	+87,705	New	+$81.3K	﹤0.01%	1618
2023 Q2	–	Sell	-14,565	Closed	-$45K	–	1468
2023 Q1	$45K	Buy	+14,565	New	+$41.4K	0.01%	1105
2022 Q2	–	Sell	-17,125	Closed	-$121K	–	1003
2022 Q1	$121K	Buy	+17,125	New	+$99.7K	0.03%	659

Other funds holding HUMA

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return

V.M. Manning & Co Greenville, South Carolina $117M AUM

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Trilogy Capital Irvine, California $2.56B AUM 22.97% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $9.96B AUM 23.61% 1-Year Est. Return

Clearview Wealth Management Irvine, California $156M AUM

Key Client Fiduciary Advisors Fairfield, New Jersey $343M AUM 35.3% 1-Year Est. Return